The Dramatic Reversal of Acute Pulmonary Embolism-Induced Corrected Qt-Interval Prolongation with Bisoprolol; a Case Report

Case Report | DOI: https://doi.org/10.31579/2690-8808/004

The Dramatic Reversal of Acute Pulmonary Embolism-Induced Corrected Qt-Interval Prolongation with Bisoprolol; a Case Report

  • Yasser Mohammed Hassanain Elsayed 1*

Critical Care Unit, Fraskour Central Hospital, Damietta Health Affairs, Egyptian Ministry of Health (MOH), Damietta, Egypt 

*Corresponding Author: Yasser Mohammed Hassanain Elsayed, Critical Care Unit, Fraskour Central Hospital, Damietta Health Affairs, Egyptian Ministry of Health (MOH), Damietta, Egypt

Citation: Hassanain Elsayed Y M. (2020) The Dramatic Reversal Of Acute Pulmonary Embolism-Induced Corrected Qt-Interval Prolongation with Bisoprolol; A Case Report. Journal of Clinical Case Reports and Studies, 1(1): DOI: 10.31579/2690-8808/004

Copyright: © 2020. Yasser Mohammed Hassanain Elsayed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 13 February 2020 | Accepted: 15 February 2020 | Published: 11 March 2020

Keywords: dramatic reversal of acute pulmonary embolism; induced corrected QT-interval prolongation; bisoprolol

Abstract

Rationale: Acute pulmonary embolism is one of the most serious cardiovascular conditions. QT-interval prolongation represents a hallmark for torsades de pointes or polymorphic ventricular tachycardia and sudden cardiac death. So, identifying the QT-interval prolongation inducer considered very important.
Patient concerns: A 55-year-old housewife woman presented with a thrombophilic acute pulmonary embolism-induced marked electrocardiographic QT-interval prolongation. Diagnosis: Acute pulmonary embolism-induced QT-interval prolongation.
Interventions: Electrocardiography, computed tomography pulmonary angiogram, and echocardiography.
Lessons: Bisoprolol may be helping in the reversal QT-interval prolongation. QT-interval prolongation that is a hallmark for torsades de pointes, and serious ventricular tachyarrhythmias with subsequent sudden cardiac death. Acute pulmonary embolism-induced QT-interval prolongation should be put among the acquired causes of the long QT syndrome.
Outcomes: Dramatic response for both electrocardiographic and clinical signs of acute pulmonary embolism-induced QT-interval prolongation post-bisoprolol. Why don’t we use bisoprolol in the management of acute pulmonary embolism-induced electrocardiographic marked QT-interval prolongation?

Introduction

Abbreviations

CDC: Centers for Disease Control and Prevention

CTPA: computed tomography pulmonary angiogram

DVT: Deep vein thrombosis

ECG: Electrocardiography

HR: heart rate

INR: International normalized ratio

IVB: Intravenous bolus

LQTS: Long QT syndrome

PE: Pulmonary embolism

TdP: Torsade de Pointes

VTE: venous thromboembolism

Pulmonary embolism and deep venous thrombosis are the two most important manifestations of venous thromboembolism (VTE), which is the third most common and frequent life-threatening cardiovascular disease [1,4] with an overall annual incidence of 100– 200 per 100 000 inhabitants [4]. According to the Centers for Disease Control and Prevention (CDC), the annual incidence of VTE is one or two per 1,000 persons, and the overall mortality rate is between 60,000 and 100,000 annually [2]. One-third of patients with VTE will have a recurrence within 10 years [2]. Approximately one-third of patients with VTE present with pulmonary embolism (PE), and two-third present with deep vein thrombosis (DVT) [1]. VTE is provoked in the presence of a temporary or reversible risk factor (such as surgery, trauma, and immobilization, pregnancy, and oral contraceptive use or hormone replacement therapy) within the last 6 weeks to 3 months before diagnosis, and ‘unprovoked’ in the absence thereof. PE may also occur in the absence of any known risk factor [4]. VTE may be lethal in the acute phase or lead to chronic disease and disability, but it is also often preventable [4]. PE is a common and potentially life-threatening condition associated with considerable morbidity and mortality [3]. An estimated 10 percent of symptomatic PE causes death within one hour of onset [3]. The constellation of symptoms and signs of PE are suggestive but do not have the necessary specificity or sensitivity to rule in or out the diagnosis. When the diagnosis is entertained, clinical stability and pre-test probability will dictate the diagnostic approach [6]. All patients with possible PE should have clinical probability assessed and documented [5]. An alternative clinical explanation should always be considered at presentation and sought when PE is excluded [5]. Blood d-dimer assay should only be considered following the assessment of clinical probability [5]. The d-dimer assay should not be performed in those with a high clinical probability of PE. A negative d-dimer test reliably excludes PE in patients with low or intermediate clinical probability; such patients do not require imaging for VTE [5]. Computed tomography pulmonary angiogram (CTPA) is now the recommended initial lung imaging modality for non-massive PE. Patients with a good quality negative CTPA do not require further investigation or treatment for PE [5]. CTPA or echocardiography will reliably diagnose clinically massive PE [5]. The electrocardiograph (ECG) is often abnormal in PE [7]. Almost 33% of patients have normal ECG [7]. Lack of specificity and sensitivity of ECG signs is key in the diagnosis of PE [7]. The most common ECG findings in PE are sinus tachycardia, complete or incomplete right bundle branch block, anteroseptal T-wave inversion/ST-elevation or depression, low QRS-complex voltage, S1Q3T3 pattern, and right axis deviation [7]. Anticoagulation is the mainstay of VTE treatment [1]. Inpatient treatment of VTE begins with parenteral agents, preferably low-molecular-weight heparin [1]. The presence of persistent—as opposed to major, temporary—risk factors may affect the decision on the duration of anticoagulation therapy after the first episode of PE [4]. Hemodynamically unstable patients with low bleeding risk may benefit from thrombolytic therapy [1]. Thrombolysis is the first-line treatment for massive PE [5].
The QT-interval is an electrocardiographic phase; it is measured in milliseconds (ms) from the beginning of the QRS-complex until the end of the T-wave [8]. The QT-interval represents the ventricular depolarization followed by the ventricular repolarization. QT-prolongation is used as a marker for a prolongation of the ventricular repolarization time [8].  A QTc-interval higher than 450 ms in adult males and higher than 470 ms in adult females is defined as prolonged QTc [8]. Because the QT-interval varies with the heart rate (HR), the corrected QT-interval (QTc-interval) should be used. Various correction formulas are available for this correction. The Bazett formula is the easiest correction and most used in clinical practice [8]. While the degree of QT prolongation is recognized as an imperfect biomarker for proarrhythmic risk, in general, there is a qualitative relationship between QT prolongation and the risk of torsade de Pointes (TdP) [9]. A prolonged QTc-interval A and delay in cardiac repolarization can lead to ventricular arrhythmias (TdP) and sudden cardiac death [8, 10]. QTc value above 500 ms or an increase of 60 ms (20% from baseline) is strongly associated with arrhythmias and TdP [10]. For risk of sudden cardiac death, "borderline QTc" in males is 431–450 ms; and, in females, 451–470 ms. An "abnormal" QTc in males is a QTc above 450 ms; and, in females, above 470 ms [11]. All patients with long QT syndrome (LQTS) should avoid drugs that prolong the QT interval or that reduce their serum potassium or magnesium levels [12]. Beta-blockers are drugs of choice for patients with LQTS [13].  The efficacy in preventing cardiac events in approximately 70% of patients with LQTS, whereas cardiac events continue to occur despite beta-blocker therapy in the remaining 30% [14].The protective effect of beta-blockers is related to their adrenergic blockade, which diminishes the risk of cardiac arrhythmias and reduces the QT interval in some patients [14].
Bisoprolol is a synthetic β1-selective (cardioselective) adrenoceptor blocking agent without significant membrane stabilizing activity or intrinsic sympathomimetic activity [15]. Bisoprolol is used to treat hypertension, arrhythmias, ischemic heart diseases, myocardial infarction, and compensated congestive heart failure [16]. The most prominent effect of bisoprolol is the negative chronotropic effect, resulting in a reduction in resting and exercise heart rate [15].

Electrophysiology studies have demonstrated that bisoprolol significantly decreases heart rate, increases sinus node recovery time, prolongs AV node refractory periods, and with rapid atrial stimulation, prolongs AV nodal conduction [15]. The absolute bioavailability after a 10 mg dose is greater than 80%. Binding to serum proteins is approximately 30%. Peak plasma concentrations occur within 2 - 4 hours of dosing with 5 to 20 mg, and mean peak values range from 16 ng/mL at 5 mg to 70 ng/mL at 20 mg. Bisoprolol is eliminated equally by renal and non-renal pathways. Bisoprolol is contraindicated in patients with cardiogenic shock, Acute or decompensated heart failure, second or third-degree A-V block, right ventricular failure secondary to pulmonary hypertension, and sinus bradycardia [15, 16]. The most frequently reported adverse reactions were: arthralgia (2.7%), dizziness (3.5%), headache (10.9%), insomnia (2.5%), diarrhea (3.5%), nausea (2.2%), coughing (2.5%), pharyngitis (2.2%), rhinitis (4.0%), sinusitis (2.2%), URT infection (5.0%), fatigue (8.2%), and peripheral edema (3%) [15].

Case presentation

A 55-year-old housewife Egyptian woman complaint of sudden transient loss of consciousness with acute central chest pain, and positional dizziness. The patient had a history of recurrent of two right, one left lower limb DVT episodes, and one attack of PE. Currently, the patient was admitted to the critical care unit. Otherwise recurrent VTE and hypertension on captopril/ hydrochlorothiazide (25/12.5mg oral tablet, once daily), the patient denied any history of other cardiac, thyroid, or other relevant diseases. Upon examination, the patient appeared irritable, sweaty, pale, and tachypneic. His vital signs were as follows: blood pressure of 180/100 mmHg, pulse rate of 85/bpm; and regular, the temperature of 36.5°C,  respiratory rate of 23/min and, oxygen saturation (pulse oxymetry) of 94%. Other examination data were unremarkable.  Blood pressure was initially controlled with captopril (25mg oral tablet, once daily) until blood pressure: 140/140 mmHg reached then was continued twice daily. Oxygen inhalation (5L/min), heparin sulfate (5000 unit, IVB), enoxaparin (80 mg, SC twice daily) warfarin was given. The initial workup was: ECG that showed normal sinus rhythm (Figure 1-A). Later serial ECG tracings showed QT/QTc prolongations (Figure 1-B, C). The patient received bisoprolol (5mg oral tablet, once daily). The last ECG tracings one day after introducing bisoprolol were showing the reversal of QT/QTc prolongation (Figure 1-D). The investigations done were: troponin test, electrolyte levels, complete blood count, thyroid studies, random blood sugar, and echocardiography with no detectable abnormal results. D-dimer was very high (4246 ng/mL). Serial INR follow up had happened until achieved 2.75. CTPA showed partially thrombosed left main pulmonary, bilateral lobar, segmental, and sub-segmental branches indicating PE (Figure 2). Complete recovery was achieved and the patient was discharged within 8 days from admission with no problem. The patient continued on oral warfarin for life (5 mg, once-daily tablet) with follow up with INR.  Bisoprolol (5mg oral tablet, once daily) with captopril (25 mg oral tablet, once daily) was added with discharge therapy. Planning for future thrombophilia investigation studies was recommended.

Discussion

Overview:

• In the current case, there was acute pulmonary embolism-induced marked electrocardiographic QT/ corrected QT-interval prolongation.

• Normal sinus rhythm in initial ECG tracings did not rule out the acute PE.

• Recurrent DVTs and PE indicate thrombophilia.

• B-blocker bisoprolol was added for the treatment of acute PE-induced QT/QTc prolongation.

• Very high d-dimer (4246 ng/mL) not indicated specificity but indicate a poor prognosis.

• Enoxaparin injection transiently postponed until blood pressure control.

• Warfarin was added for life due to recurrent thromboembolism with serial INR follow up.

• Hydrochlorothiazide and diuretics not preferable with thrombophilia due to volume depletion and hemoconcentration.

• I can’t compare the current case with similar conditions. There are no similar or known cases with the same management for near comparison.

Study question here; how did QT/corrected QT-interval prolongation finally reversed after oral bisoprolol?

The primary objective for my case study was induced marked electrocardiographic QT/ corrected QT-interval prolongation by acute pulmonary embolism.

The secondary objective for my case study was the appearance of clearing the clinical impact of bisoprolol on electrocardiographic QT/ corrected QT-interval prolongation.

Limitations of the study

There are no known limitations in the study. But, contraindications of b-blockers are possible limitations.

Recommendations

It is recommended to widening the research in clearing the effect of bisoprolol on QT/corrected QT-interval prolongation

Also, it is recommended to extend the research on the impact of other b-blockers on QT/corrected QT-interval prolongation.

Conclusion

Acute PE induced-QT/QTc prolongation should be included among the acquired causes of the LQTS.

• B-blocker should be added for prophylaxis and treatment acute PE-induced QT/QTc prolongation to avoid TdP and serious ventricular tachyarrhythmias with subsequent sudden cardiac death. This need further larger studies will need for confirmation.

• Prolonged QT/QTc is considered a novel predictor for evaluating outcomes in acute PE.

• Warfarin should be added for life in recurrent thromboembolism with serial INR follow up.

• Planning for future thrombophilia investigation studies was recommended.

Figure 1: Serial ECG  tracings showing; A. tracing; Showing NSR with (VR:85,QT:381 ms,QTC:453 ms):(green arrows)  B. tracing:(VR:61 bpm,QT:480 ms,QTC:487 ms) C. tracing; (VR:67 bpm,QT:,473 ms, QTC:502 ms) :(blue arrows)   D. tracing; (VR:66, bpm QT:442 ms,QTC:464 ms) :(green arrows).
Figure 2: CTPA; a: showing partially thrombosed left main pulmonary (orange arrows). b: showing thrombosed segmental, and sub-segmental branches (rose arrows).

Conflicts of interest

There are no conflicts of interest

Acknowledgement

I wish to thank Dr. Ameer Mekkawy; M.sc. for technical support, and critical care unit nurses who make extra ECG copy for helping me.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad